<DOC>
	<DOCNO>NCT02602613</DOCNO>
	<brief_summary>A multi center study evaluate safety AMENDTM Mitral Valve Repair System ability reduce mitral regurgitation . AMEND device annuloplasty ring implant minimally invasive trans-catheter method .</brief_summary>
	<brief_title>AMENDTM Mitral Valve Repair System , Annuloplasty Ring Applied Transcatheter Method</brief_title>
	<detailed_description />
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>Patient age ≥18 The patient require mitral valve annuloplasty mitral regurgitation without need concomitant cardiovascular surgical procedure NYHA functional capacity ≥2 The subject high risk undergo mitral valve surgery assess center heart team The patient willing comply study procedure available return implant center followup visit . The patient willing provide Informed consent Cardiac noncardiac major progressive disease , investigator 's discretion produce unacceptable increase risk patient . Life expectancy less twelve month . Heavily calcify annulus leaflet . Previous active endocarditis . Active infection . A previously implant prosthetic mitral valve annuloplasty ring/band . The patient contraindicate general anesthesia . Pregnant ( urine HCG test result positive ) lactate patient . Drug alcohol abuse . Participation concomitant research study investigational product interfere study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>